JP2022501055A5 - - Google Patents

Info

Publication number
JP2022501055A5
JP2022501055A5 JP2021517046A JP2021517046A JP2022501055A5 JP 2022501055 A5 JP2022501055 A5 JP 2022501055A5 JP 2021517046 A JP2021517046 A JP 2021517046A JP 2021517046 A JP2021517046 A JP 2021517046A JP 2022501055 A5 JP2022501055 A5 JP 2022501055A5
Authority
JP
Japan
Prior art keywords
seq
expression vector
conjugated
pharmaceutical composition
vector according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021517046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022501055A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/053260 external-priority patent/WO2020069194A1/en
Publication of JP2022501055A publication Critical patent/JP2022501055A/ja
Publication of JP2022501055A5 publication Critical patent/JP2022501055A5/ja
Pending legal-status Critical Current

Links

JP2021517046A 2018-09-26 2019-09-26 未成熟終止コドン媒介性障害を治療するための方法および組成物 Pending JP2022501055A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862736834P 2018-09-26 2018-09-26
US62/736,834 2018-09-26
US201862747646P 2018-10-18 2018-10-18
US62/747,646 2018-10-18
US201962805793P 2019-02-14 2019-02-14
US62/805,793 2019-02-14
PCT/US2019/053260 WO2020069194A1 (en) 2018-09-26 2019-09-26 Methods and compositions for treating a premature stop codon-mediated disorder

Publications (2)

Publication Number Publication Date
JP2022501055A JP2022501055A (ja) 2022-01-06
JP2022501055A5 true JP2022501055A5 (cg-RX-API-DMAC7.html) 2022-10-04

Family

ID=69949797

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021517046A Pending JP2022501055A (ja) 2018-09-26 2019-09-26 未成熟終止コドン媒介性障害を治療するための方法および組成物

Country Status (6)

Country Link
US (3) US10905778B2 (cg-RX-API-DMAC7.html)
EP (1) EP3856253A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022501055A (cg-RX-API-DMAC7.html)
AU (1) AU2019350869A1 (cg-RX-API-DMAC7.html)
CA (1) CA3114108A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020069194A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108603230A (zh) 2015-10-09 2018-09-28 南安普敦大学 基因表达的调节与蛋白质表达失调的筛选
CN116059236A (zh) 2015-12-14 2023-05-05 冷泉港实验室 用于治疗常染色体显性精神发育迟滞5型和Dravet综合征的反义寡聚体
KR20260009385A (ko) 2017-08-25 2026-01-19 스톡 테라퓨틱스, 인크. 병태 및 질환 치료용 안티센스 올리고머
MX2020004587A (es) 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
JP2021523227A (ja) 2018-05-04 2021-09-02 ストーク セラピューティクス,インク. コレステリルエステル蓄積症の処置のための方法及び組成物
KR20210134003A (ko) 2019-02-27 2021-11-08 스톡 테라퓨틱스, 인크. 병태 및 질환의 치료를 위한 안티센스 올리고머
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
BR112022020780A2 (pt) 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US12338437B2 (en) 2020-05-11 2025-06-24 Stoke Therapeutics, Inc. OPA1 antisense oligomers for treatment of conditions and diseases
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
WO2022118966A1 (ja) * 2020-12-04 2022-06-09 国立大学法人京都大学 細胞内への核酸分子取り込み促進剤、医薬組成物、及び新規化合物
EP4334450A4 (en) * 2021-05-05 2025-06-18 Tevard Biosciences, Inc. Methods and compositions for treating a premature termination codon-mediated disorder
CA3235264A1 (en) * 2021-10-13 2023-04-20 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods of use
EP4202045A1 (en) * 2021-12-22 2023-06-28 Universität Hamburg Synthetic transfer rna with modified nucleotides
EP4442826A1 (en) 2023-04-06 2024-10-09 Universität Hamburg Synthetic dna construct encoding transfer rna
EP4458967A1 (en) 2023-05-02 2024-11-06 Universität Hamburg Pharmaceutical composition comprising multiple suppressor transfer rnas
TW202521693A (zh) * 2023-08-11 2025-06-01 大陸商上海科動生物技術有限公司 工程化抑制性tRNA分子和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法
WO2017049409A1 (en) * 2015-09-25 2017-03-30 The Centre For Drug Research And Development Compositions for promoting readthrough of premature termination codons, and methods of using the same
CN107177592B (zh) * 2016-03-10 2021-03-30 北京大学 抑制性tRNA通读提前终止密码子疾病中的截短蛋白
PL3458074T3 (pl) * 2016-05-16 2024-11-12 Board Of Regents Of The University Of Texas System KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA
CN110612353A (zh) * 2017-03-03 2019-12-24 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
MX2020004587A (es) * 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.

Similar Documents

Publication Publication Date Title
WO2019060454A3 (en) Adeno-associated virus variant capsids and methods of use thereof
MX2020005451A (es) Capsides variantes de virus adenoasociados y uso para inhibir la angiogenesis.
WO2017189964A3 (en) Compositions for the treatment of disease
JP2003535043A5 (cg-RX-API-DMAC7.html)
JP2018520997A5 (cg-RX-API-DMAC7.html)
JP2018148890A5 (cg-RX-API-DMAC7.html)
WO2022098699A8 (en) Compositions and methods for the treatment of tauopathy
JP2019530462A5 (cg-RX-API-DMAC7.html)
WO2017197355A3 (en) Adeno-associated virus variant capsids and methods of use thereof
JP2012136541A5 (cg-RX-API-DMAC7.html)
RU2013119416A (ru) Процесс получения поксвирусов и композиции поксвирусов
MX2020000221A (es) Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas.
JP2017113019A5 (cg-RX-API-DMAC7.html)
JP2016513115A5 (cg-RX-API-DMAC7.html)
JP2008534594A5 (cg-RX-API-DMAC7.html)
Rodríguez Stewart et al. Enhanced killing of triple-negative breast cancer cells by reassortant reovirus and topoisomerase inhibitors
WO2001089559A3 (en) Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
JP2006506942A5 (cg-RX-API-DMAC7.html)
JP2005237328A5 (cg-RX-API-DMAC7.html)
JP2019531293A5 (cg-RX-API-DMAC7.html)
WO2020219766A8 (en) Compositions useful in treatment of rett syndrome
JP2006511212A5 (cg-RX-API-DMAC7.html)
JP2008508899A5 (cg-RX-API-DMAC7.html)
JPWO2020071318A5 (cg-RX-API-DMAC7.html)
JP2005524719A5 (cg-RX-API-DMAC7.html)